PepGen Inc. (NASDAQ: PEPG) is a Healthcare company (Biotechnology) with a market capitalization of $263M. The Maz Rating grades it against the other companies in its sector.
PepGen Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.80, PepGen Inc. trades at 2.8x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -58.2%, return on invested capital of -65.7% and a free cash flow yield of -21.8%. On the balance sheet: a debt-to-equity ratio of 0.15 and a current ratio of 8.70. Over the past 52 weeks the share price ranged from $1.31 to $7.80, with a beta of 2.01.
PepGen Inc. does not currently pay a dividend.
6 Wall Street analyst ratings cover the stock: 5 Buy and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.